Posts tagged with ‘marine organism’

  • Marine Natural Product Yields Cancer Therapeutic (NCE)

    SIO scientists have mined their rare collection of marine organisms to identify, characterize and analog a proprietary, small molecule with anti-cancer properties. SAR studies have identified regions of the molecule that have yielded analogs of greatest interest. Compositions of matter and methods of use are claimed for the treatment of cancer and hyperproliferative disorders. SUGGESTED USES While in vivo studies have not confirmed which drugs […]
    0
  • Toxins from algae prove in demand

    Nelson’s Cawthron Institute has broken into an international market selling minute quantities of organic compounds sourced from algae and worth 50,000 times the price of gold. A level teaspoon of the compounds was worth several million dollars, acting chief executive Daryl Wehner said today. “Our sales over the first nine months have exceeded a quarter of a million dollars and […]
    0
  • Marine Drugs Announces New Issue: Mar. Drugs, Volume 10, Issue 3

    MDPI recently announced the publication of the following issue: Mar. Drugs, Volume 10, Issue 3 (March 2012), Pages Pages 521-676 http://www.mdpi.com/1660-3397/10/3/   Table of Contents: Jing Tong, Hank Trapido-Rosenthal, Jun Wang, Youwei Wang, Qing X. Li and Yuanan Lu Article: Antiviral Activities and Putative Identification of Compounds in Microbial Extracts from the Hawaiian Coastal Waters Mar. Drugs 2012, 10(3), 521-538; […]
    0
  • Mar. Drugs, Volume 9, Issue 12 (December 2011), Pages 2488-2817 Release issue

    MDPI is pleased to announce the publication of the following issue:Mar. Drugs, Volume 9, Issue 12 (December 2011), Pages 2488-2817 at http://www.mdpi.com/1660-3397/9/12/ Table of Contents: Jeen-Kuan Chen, Chao-Hsien Yeh, Lian-Chen Wang, Tzong-Horng Liou, Chia-Rui Shen and Chao-Lin Liu Article: Chitosan, the Marine Functional Food, Is a Potent Adsorbent of Humic Acid Mar. Drugs 2011, 9(12), 2488-2498; doi:10.3390/md9122488 http://www.mdpi.com/1660-3397/9/12/2488/ Oriol Sacristan-Soriano, Bernard […]
    0
  • Aquapharm and CABI sign collaborative agreement

    Scottish marine biotechnology firm Aquapharm has signed an agreement with the Centre for Agricultural Bioscience International (CABI) which will allow the organisations to access and co-promote one another’s unique microbe collections. Aquapharm specialises in the discovery, isolation and development of novel functional active ingredients, sustainably harvested from marine micro-organisms for potential use in a wide range of commercial sectors. Meanwhile […]
    0
  • Aquapharm Biodiscovery renews deal with Croda/Sederma, harnessing Aquapharm’s collection of marine micro-organisms for cosmetics

    Leading Scottish marine biotechnology company, Aquapharm Biodiscovery Ltd, has reached a crucial new stage in the development of next generation cosmetics harnessing its unique collection of marine micro-organisms. Aquapharm, which signed a three year R&D agreement with Croda, a global leader in speciality chemicals for the personal care market in 2008, has struck a renewed deal to work with Croda’s […]
    0
  • Partner sought in development and fermentation of compounds from natural marine origin

    A Spanish company located in the North of Spain with microbiological and fermentation expertise, is looking for companies interested in compounds for research and/or preclinical and clinical development with diverse applications for medicine, cosmetics, agriculture, biodiesel, nutraceuticals, etc. Joint further development and joint venture agreements are offered. The biotechnology company is engaged in discovering and developing novel bioactive compounds from […]
    0
  • New Publication Details Leiodermatolide, a Potent Antimitotic Macrolide from the Marine Sponge

    Leiodermatolide is a structurally unique macrolide isolated from the deep-water marine sponge Leiodermatium sp. which exhibits potent antiproliferative activity against a range of human cancer cell lines and drastic effects on spindle formation in mitotic cells. Its unprecedented polyketide skeleton and stereochemistry were established using a combination of experimental and computational NMR methods. Paterson, I., Dalby, S. M., Roberts, J. […]
    0
  • NineSigma Seeks Natural Compound Collections for Screening: invites proposals for the purchase of natural compound collections

    NineSigma reports that they are looking for proposals for the purchase of natural compound collections for screening. The compounds may be pure or extracts (fractionated or not) or semi-synthetic but must be derived from sustainable natural sources. They are interested in compound collection acquisition, licensing, supplier agreement. Co-development of any discovered activities is also possible. Description Collection(s) will be screened in […]
    0
  • EVENT – UC San Diego: Pharmaceuticals from the Sea — using marine microorganisms in unimaginable ways

    Pharmaceuticals from the Sea: Using marine microorganisms in unimaginable ways Presented by: Dr. William Gerwick Professor, Center for Marine Biotechnology and Biomedicine Scripps Institution of Oceanography & Skaggs School of Pharmacy and Pharmaceutical Sciences UC San Diego Date: Wednesday, January 26, 2010 Time: 12:00 – 1:30 p.m. Location: AMN Healthcare 12400 High Bluff Drive # 100 San Diego, CA 92130 […]
    0